Myeloperoxidase in kidney disease

Area of Science:

• Nephrology
• Oxidative Stress Biology
• Immunology

Background:

• Reactive oxygen species from immune cells contribute to oxidative damage in kidney diseases.
• Myeloperoxidase (MPO) is a key enzyme in mononuclear cells, catalyzing (lipo)protein oxidation.
• The MPO-hydrogen peroxide-chloride system generates chlorinated adducts, potentially causing kidney cell dysfunction.

Purpose of the Study:

• To interpret experimental and clinical aspects of MPO's role in glomerular and tubulointerstitial diseases.
• To evaluate the MPO-hydrogen peroxide-chloride system's contribution to renal disease progression and attenuation.
• To explore the complex, bimodal effects of MPO in redox-modulated renal diseases.

Main Methods:

• Review of experimental and clinical data on MPO and HOCl-modified proteins in various kidney diseases.
• Analysis of MPO colocalization with HOCl-modified proteins in human glomerulonephritis and tubulointerstitial disease.
• Examination of MPO antibody complexes in necrotizing glomerulonephritis and urinary HOCl epitopes in hyperlipidemia models.

Main Results:

• MPO and HOCl-modified proteins are found in glomeruli, podocytes, interstitium, and damaged tubular epithelia in human kidney diseases.
• MPO antibody complexes exacerbate inflammation in necrotizing glomerulonephritis.
• HOCl epitopes are detected in urine after hyperlipidemia-induced renal damage in rodents.

Conclusions:

• MPO is an important pathogenic factor in glomerular and tubulointerstitial diseases.
• The MPO-hydrogen peroxide-chloride system has a complex role, potentially being both detrimental and beneficial in renal disease.
• MPO's interaction with nitric oxide metabolism contributes to its multifaceted effects in redox-modulated kidney diseases.